Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Choiceone Financial
COFS
$513M
| $541K | ﹤0.01% |
18,457
| – | – |
|
3052
374Water
SCWO
$39.7M
| $540K | ﹤0.01% |
38,009
+448
| +1% | +$5.98K |
|
3053
Alico
ALCO
$314M
| $538K | ﹤0.01% |
18,485
| – | – |
|
3054
Weyco Group
WEYS
$430M
| $536K | ﹤0.01% |
17,093
| – | – |
|
3055
PCB Bancorp
PCB
$396M
| $535K | ﹤0.01% |
29,027
| – | – |
|
3056
Pulse Biosciences
PLSE
$3.1B
| $535K | ﹤0.01% |
43,695
| – | – |
|
3057
Red Robin
RRGB
$155M
| $534K | ﹤0.01% |
42,799
-2,816
| -6% | -$26.3K |
|
3058
Escalade
ESCA
$285M
| $534K | ﹤0.01% |
26,565
| – | – |
|
3059
Prelude Therapeutics
PRLD
$442M
| $532K | ﹤0.01% |
124,700
+1,669
| +1% | +$5.08K |
|
3060
Offerpad Solutions
OPAD
$22.2M
| $532K | ﹤0.01% |
5,187
+84
| +2% | +$7.62K |
|
|
TEF
3061
DELISTED
Telefonica
TEF
| $525K | ﹤0.01% |
134,598
+20,146
| +18% | +$80.9K |
|
3062
Quantum-Si Incorporated
QSI
$187M
| $524K | ﹤0.01% |
260,595
-16,360
| -6% | -$24.9K |
|
3063
MeiraGTx Holdings
MGTX
$1.2B
| $523K | ﹤0.01% |
74,544
| – | – |
|
3064
Ovid Therapeutics
OVID
$483M
| $521K | ﹤0.01% |
161,808
-8,228
| -5% | -$28.1K |
|
|
NOTE
3065
DELISTED
FiscalNote
NOTE
| $519K | ﹤0.01% |
37,971
-5,263
| -12% | -$86.8K |
|
|
INZY
3066
DELISTED
Inozyme Pharma
INZY
| $518K | ﹤0.01% |
121,650
+27,655
| +29% | +$98.3K |
|
3067
Evolution Petroleum
EPM
$134M
| $513K | ﹤0.01% |
88,329
| – | – |
|
3068
Amprius Technologies
AMPX
$1.79B
| $513K | ﹤0.01% |
96,964
+1,540
| +2% | +$5.79K |
|
3069
National Bankshares
NKSH
$269M
| $508K | ﹤0.01% |
15,718
| – | – |
|
3070
Rigetti Computing
RGTI
$6.11B
| $507K | ﹤0.01% |
514,794
+9,605
| +2% | +$10.9K |
|
3071
AMES National
ATLO
$281M
| $507K | ﹤0.01% |
23,759
| – | – |
|
3072
LiveWire
LVWR
$221M
| $504K | ﹤0.01% |
44,591
+19,395
| +77% | +$190K |
|
|
QIPT
3073
DELISTED
Quipt Home Medical
QIPT
| $498K | ﹤0.01% |
97,906
+5,675
| +6% | +$27.2K |
|
3074
Ispire Technology
ISPR
$98.7M
| $496K | ﹤0.01% |
+40,909
| New | +$419K |
|
|
ALLK
3075
DELISTED
Allakos
ALLK
| $496K | ﹤0.01% |
181,731
| – | – |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.